Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 1:01 pm Purchase | 13G | Guardian Pharmacy Services Inc. GRDN | Woodline Partners LP | 568,131 6.200% | 568,131 (New Position) | View |
2024-11-14 1:01 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Woodline Partners LP | 4,340,340 5.700% | 4,340,340 (New Position) | View |
2024-11-14 1:00 pm Purchase | 13G | PROTARA THERAPEUTICS INC TARA | Woodline Partners LP | 1,576,567 7.400% | 1,576,567 (New Position) | View |
2024-11-14 1:00 pm Purchase | 13G | ZEVRA THERAPEUTICS INC ZVRA | Woodline Partners LP | 4,048,653 7.700% | 4,048,653 (New Position) | View |
2024-02-12 4:38 pm Purchase | 13G | Vera Therapeutics Inc. VERA | Woodline Partners LP | 1,140,632 2.200% | 1,140,632 (New Position) | View |
2024-02-12 4:33 pm Sale | 13G | CALIDI BIOTHERAPEUTICS INC CL CLDI | Woodline Partners LP | 125,000 0.400% | -275,000 (-68.75%) | View |
2024-02-12 4:32 pm Sale | 13G | Opy Acquisition Corp. I OHAA | Woodline Partners LP | 0 0.000% | -200,000 (Position Closed) | View |
2023-02-10 4:10 pm Sale | 13G | Ascendant Digital Acquisition Corp. III ACDI | Woodline Partners LP | 1,286,000 4.300% | -626,500 (-32.76%) | View |
2023-02-10 4:10 pm Purchase | 13G | Opy Acquisition Corp. I OHAA | Woodline Partners LP | 200,000 8.100% | 200,000 (New Position) | View |
2023-02-10 4:09 pm Unchanged | 13G | SENTI BIOSCIENCES INC SNTI | Woodline Partners LP | 0 0.000% | 0 (Unchanged) | View |
2023-02-10 4:08 pm Sale | 13G | CALIDI BIOTHERAPEUTICS INC CL CLDI | Woodline Partners LP | 400,000 9.700% | -1,580,000 (-79.80%) | View |
2022-02-11 07:26 am Purchase | 13G | SENTI BIOSCIENCES INC SNTI | Woodline Partners LP | 2,000,000 8.400% | 2,000,000 (New Position) | View |
2022-02-11 07:25 am Purchase | 13G | Ascendant Digital Acquisition Corp. III ACDI | Woodline Partners LP | 1,912,500 6.400% | 1,912,500 (New Position) | View |
2022-02-11 07:23 am Purchase | 13G | CALIDI BIOTHERAPEUTICS INC CL CLDI | Woodline Partners LP | 1,980,000 8.600% | 1,980,000 (New Position) | View |
2022-02-11 07:22 am Unchanged | 13G | MARKETWISE INC. MKTW | Woodline Partners LP | 0 0.000% | 0 (Unchanged) | View |
2022-02-11 07:20 am Purchase | 13G | Eledon Pharmaceuticals Inc. ELDN | Woodline Partners LP | 685,273 4.800% | 685,273 (New Position) | View |
2021-02-16 4:35 pm Purchase | 13G | Eledon Pharmaceuticals Inc. ELDN | Woodline Partners LP | 814,756 5.400% | 814,756 (New Position) | View |
2021-02-16 4:34 pm Purchase | 13G | MARKETWISE INC. MKTW | Woodline Partners LP | 4,008,770 9.700% | 674,214 (+20.22%) | View |
2020-07-31 5:04 pm Purchase | 13G | MARKETWISE INC. MKTW | Woodline Partners LP | 3,334,556 8.100% | 3,334,556 (New Position) | View |